GMP Facility Expected to Simplify the mRNA Drug Substance Development Process; Slated to Welcome Customers in Early 2024 SAN DIEGO –TriLink BioTechnologies (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has announced the expansion of its mRNA manufacturing capabilities to serve late-phase drug developers. TriLink’s construction of the new 32,000-square-foot, cGMP-grade […]
Traditional DNA synthesis has long been plagued by slow, low-quality results, creating a bottleneck for researchers and impeding progress in both academic and industrial fields; in response, GenScript has launched a groundbreaking solution with the first and only commercial miniature semiconductor platform that utilizes integrated circuits to deliver high-throughput DNA synthesis. OAKLAND, Calif. — (#SynBioBeta2023, […]
The cutting-edge software integration enables researchers to design oligo assembly reactions, automate the reaction setup, order the needed DNA, and integrate with lab automation, all within a single platform PORTOLA VALLEY, Calif. — TeselaGen Biotechnology Inc., pioneer in AI-enabled Operating Systems for Biotechnology R&D and Manufacturing announces a strategic partnership with NinthBio LLC, the visionary Smart DNA Assembly […]
Facility will have capacity that exceeds today’s global plasmid DNA demand and can enable commercialisation of genetic medicines. Transformation of Grade II-listed Victorian waterworks on the River Thames in Hampton, London. Supplying many of the top biopharmaceutical companies in the world to dramatically enhance their ability to develop genetic medicines. Expansion follows recent acceptance of a Drug […]
SOPHiA DDM™ deep-learning algorithm will help determine HRD status of tumors for Institute of Oncology Ljubljana researchers BOSTON and LAUSANNE, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that the Institute of Oncology Ljubljana (IOL), a comprehensive public institution for detection, treatment and research of cancer, based […]
SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the appointment of Robert Werner as chief accounting officer. “Rob has a proven track record of leading corporate and technical accounting, including for global companies as they grow in […]
Fully automated SYNTAX platform features latest STX-200 system, enzymatic biochemistry advances, and ready-to-use reagents for producing up to 96 oligos that are up to 120 nt long in less than a day PARIS and SOUTH SAN FRANCISCO, Calif. – DNA Script, the worldwide leader in Enzymatic DNA Synthesis (EDS) technology, today announced the broad commercial availability […]
Ansa successfully synthesized and delivered challenging promoter sequences with high GC and AT content to its first Early Access customer, Enoda, which were used to engineer gene expression. Ansa’s proprietary next-generation enzymatic DNA synthesis technology overcomes the limitations of traditional methods, giving scientists access to accurate complex DNA, quickly and reliably. EMERYVILLE, Calif. — Ansa […]
– Precision diagnostics crucial for targeted cancer treatment Qlucore, a company listed on Nasdaq First North, is in the process of obtaining CE certification for its cancer diagnostic software. The company has contracted the British Standards Institution (BSI) as the Notified Body to conduct the Conformity Assessment of Qlucore Diagnostics‘ acute lymphoblastic leukemia devices. BSI […]
High-quality enzymes now available as individual products, allowing researchers worldwide to customize their assays and workflows Dedicated web shop to easily find enzymes for a wide range of applications, including DNA cloning and amplification Strict quality control and physical purity assessment; all enzymes produced on QIAGEN’s own ISO and GMP certified manufacturing facilities Venlo, the […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
